Dermata Therapeutics Inc banner

Dermata Therapeutics Inc
NASDAQ:DRMA

Watchlist Manager
Dermata Therapeutics Inc Logo
Dermata Therapeutics Inc
NASDAQ:DRMA
Watchlist
Price: 1.29 USD 7.5% Market Closed
Market Cap: $3.7m

Intrinsic Value

DRMA doesn't have a meaningful market cap.

The intrinsic value of one DRMA stock under the Base Case scenario is 2.65 USD. Compared to the current market price of 1.29 USD, Dermata Therapeutics Inc is Undervalued by 51%.

DRMA Intrinsic Value
2.65 USD
Undervaluation 51%
Intrinsic Value
Price $1.29
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $2.12
Get notified when the price drops into your buy zone
Intrinsic Value $2.65
Margin of Safety 20% $2.12
Current Price $1.29
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about DRMA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DRMA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Dermata Therapeutics Inc.

Explain Valuation
Alternatives to DRMA

Wall St
Price Targets

Dividends

Dermata Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

DRMA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DRMA stock?

The intrinsic value of one DRMA stock under the Base Case scenario is 2.65 USD.

Is DRMA stock undervalued or overvalued?

Compared to the current market price of 1.29 USD, Dermata Therapeutics Inc is Undervalued by 51%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett